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prostate cancer. The major expected benefit of PGS should be a 
reduction of the high-dose levels to the rectal wall, rather than a 
prostate spatial fixation by-standing effect. 
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Purpose/Objective: Prostate patients at our hospital are treated to 
74Gy using a full-bladder drinking protocol, which is intended to 
improve seminal vesicle stability and reduce dose to bowel and 
bladder. Tomotherapy Planned Adaptive (TomoPA) permits dose 
distribution evaluation using daily MVCT imaging and is frequently 
used to assess the dosimetric impact of subjectively-defined 
incompliance with the drinking protocol. To optimise the clinical 
workflow, a simple, consistent method is needed to identify situations 
in which plan adaptation may be required. 
Materials and Methods: For each of 6 prostate patients receiving 
Tomotherapy,selected due to poor compliance with drinking protocol, 
4 MVCT scans showing large reductions in bladder volume were 
transferred to TomoPA. Bladder and bowel were contoured on the 
MVCT and the dose distribution recalculated. Compliance with 
PIVOTAL Trial protocol constraints was quantified. A single observer 
investigated various potential metrics (i.e. absolute and relative 
reductions in (i) bladder volume and (ii)bladder extension superior to 
prostate apex) to determine the optimal criteria for referral to 
TomoPA. 
Results: 5/24 MVCT scans were rejected due to limited scan length 
rendering identification of relevant bladder and bowel unreliable. In 
the remaining 19 scans, the lower dose PIVOTAL bowel constraints 
(i.e. V45<158cc,V50<110cc, V55<28cc) were always met, regardless of 
bladder volume reduction, while higher dose constraints (i.e. 
V60<6cc, V65=0cc) were exceeded only twice, in the same patient. 
‘Mandatory’ bladder tolerances (i.e.V65<50%, V70<30%) were 
exceeded in only 2/19 instances, although failure to meet ‘optimal’ 
constraints (V50<50%, V60<25%, V70<5%) was widespread in this 
cohort. The 1cm PTV margins adequately enclosed the seminal 
vesicles (>56.2Gy) in all cases. No metric consistently predicted 
dosimetric impact, although>50% bladder volume reduction from 
initial planning CT appeared to coincide with sharp increases in dose 
for both bowel (see figure) and bladder. Bladder volume could be 
measured for this purpose with an abdominal ultrasound probe prior 
to the patient entering the treatment room. Potential use of linear 
change in bladder extension, (ruler measurement on the MVCT image) 
as a predictive metric that would be easily identifiable prior to 
treatment and require minimal additional time, warrants further 
study, although the current cohort did not demonstrate a strong 
correlation in this regard. 
 
  
Conclusions: Tomotherapy prostate plans appear robust to large 
bladder volume changes, with dosimetric tolerances exceeded in only 
a few extreme cases. A bladder volume reduction >50% suggests that 
dosimetric evaluation may be warranted, although confirmation on a 
larger cohort is required prior to clinical implementation. 
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Purpose/Objective: The purpose of this study is to evaluate an offline 
adaptive IGRT protocol. Kilovoltage cone-beam CTs (CBCT) acquired 
during the first radiotherapy treatment sessions were used to adapt 
the PTV individually to variable organ filling and variation in 
positioning. Variation in rectum dose was studied. 
Materials and Methods: Eighteen patients post-prostatectomy with 
biochemical or macroscopic relapse in the prostate bed and two 
patients with localized prostate cancer, who underwent primary 3D 
conformal radiotherapy, were evaluated. The patients received 66.6 
to 76.2Gy (1.8Gy x 5weekly). All patients started radiotherapy with a 
4 field box technique to at least 18Gy. Then the treatment was 
continued with a VMAT technique on either the same or the modified 
PTV. The kV-CBCTs acquired in the first three fractions were 
transferred to the planning systems (Masterplan, Nucletron 
Netherlands and Eclipse, Varian Palo Alto CA) and registered with the 
planning CT. The rectum was delineated in all CBCTs (from below 
sigmoid flexure to above anal verge) and transferred to the planning 
CT. The PTV was adapted taking significant variation in organ filling 
and positioning into account. For planning CT and CBCTs V35 and V60 
(volume of organ in % that achieved 35Gy or 60Gy) for rectum were 
evaluated. The maximum dose to femoral head and femoral neck 
were evaluated in the planning CT. The modification of the PTV was 
estimated. 
Results: Variability of rectum during radiotherapy treatment 
influences the final administered rectum dose in comparison to 
planning CT and may influence the PTV. After the evaluation of the 
CBCTs, the PTV was modified for 15 of 20 patients. The changes of 
PTV had a range of 82 to -31cm³. Four PTVs were enlarged and nine 
reduced. The mean change of volume was 21cm³ with a standard 
deviation of 20cm³. In the planning CT the mean V35 for rectum over 
all patients was 52% with a standard deviation of 11%. The mean 
individual changes of V35 in planning CT and CBCTs for the rectum 
were 39 to 80% with a standard deviation of 1 to 13%. The maximal 
dose to femoral heads was 42Gy with a standard deviation of 9Gy. 
Conclusions: An evaluation of rectum volumes in the CBCTs of the 
first IGRT treatments results in a more realistic estimation of rectal 
dose and makes an adaptation of the PTV to individual variability in 
organ fillings and positioning uncertainties feasible. Commencing 
prostate treatments with a box technique and changing to a VMAT 
technique, after the PTV modification, is less time-consuming and still 
enables constrains for organs at risk to be fulfilled. 
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Purpose/Objective: To evaluate the need to correct full daily 
variation in patient anatomy and set-up when intensity-modulated 
radiotherapy (IMRT) is delivered in prostate and head and neck cancer 
patients with the Protura 6 DOF robotic couch (CIVCO Medical 
Solution). 
Materials and Methods: Prostate and H&N cancer patients treated 
with IMRT were selected for this study. Before starting radiation 
treatment each patient underwent a CT scan for radiotherapy 
planning. Prostate cancer patients were simulated in supine position 
with the dual leg CIVCO support system; conventional thermoplastic 
masks were used for immobilization of H&N patients. All patients 
received a daily CBCT before treatment to display the patient position 
and to detect necessary corrections. Geometrical shifts (3-Traslational 
and 3-Rotational) were identified by manual and/or automatic 3D 
match (Varian 6D Online Review System) and were then applied to the 
Protura 6 DOF robotic couch and recorded. Mean translational and 
rotational corrections and the/a 3D vector of displacement were 
calculated. 
Results: From October to December 2012, 5 prostate and 3 H&N 
patients were included in this ongoing study. One hundred and sixty 
CBCT studies were analyzed and compared. The mean (±SD) 
interfraction displacement of the translational corrections for 
prostate vs H&N patients were -0.2 ± 0.3 vs 0,1 ± 0,2 cm, 0.0 ± 0.3 vs 
0,2 ± 0,2 cm and -0.2 ± 0.5 vs 0,0 ± 0,3 cm in vertical, lateral and 
longitudinal direction. We observed a maximal translation shift (MTS) 
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of 1.4 cm vertically, 1.6 cm longitudinally and 1 cm laterally in 
prostate cancer patients and 0.5 cm vertically or longitudinally and 
0.7 cm laterally in H&N patients. In prostate cancer patients the 98% 
of the MTS were less then 1 cm, while in H&N patients the MTS was 
less than 0.5 cm in 92% of the cases. Therefore the mean (±SD) 3D 
vector of displacement was 0.3±0.7 cm and 0,2±0,4 cm for the 
prostate and H&N group respectively. The magnitude of roll variation 
was greater in both groups (mean (±SD) of -0.5±1.2° in prostate and a 
maximal value of 3.8° and a mean (±SD) of 1.3±1,2 ° in H&N with a 
maximal value of 3.4°). The pitch variations were greater for patients 
treated to the pelvis (means (±SD) of -0.4±1.1° vs -0.1±0.8° with a 
maximal value of 2.8° vs 1.9°), while the mean (±SD) interfractional 
yaw was 0.1±0.7° in prostate and 0.0±0.6° in H&N patients. No 
correlation was observed between the magnitude of translational and 
rotational shift in either group. The procedure of online correction 
added less than one minute to the treatment time when compared to 
IGRT without robotic 6 DOF couch. The total treatment time (±SD) 
(IGRT plus delivery) was: 14.52±2.02 min., 15.26±1.52 min., 
24.53±5.47 min. for prostate RapidArc, brain RapidArc and H&N IMRT 
respectively.  
  
Conclusions: This data confirms the relevance of rotational shifts in 
prostate and H&N patients. The correlation between immobilization 
systems and the rotational shift value is not strong enough to refrain 
from implementing the robotic couch in IGRT high precision 
radiotherapy treatments. 
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Purpose/Objective: The aim of this study is to analyze the correlation 
between a shift in the center of gravity (CoG) of the prostate and 
deformation of the prostate surface in image-guided radiation therapy 
(IGRT). 
Materials and Methods: Planning computed tomography (pCT) images 
were acquired using a conventional CT simulator and weekly cone-
beam computed tomography (CBCT) images were acquired using a 
linear accelerator-mounted kilovoltage image system in the treatment 
delivery room for 10 prostate cancer patients. The prostate was 
delineated on pCT and CBCT images by a single observer. Each CBCT 
image was registered with the corresponding pCT image using rigid 
bone registration. Then, shifts in the CoG of the prostate on pCT and 
CBCT images were calculated. Next, deformation of the prostate 
surface on pCT and CBCT images were estimated by rigid image 
registration based on translation of the CoG for the prostate. Further, 
we analyzed the correlation between shifts in the CoG and 
deformation of the prostate surface. Analysis was performed using in-
house software. 
Results: In this study, no significant variations in prostate volume 
were observed. Average shifts of the CoG of the prostate (±1 standard 
deviation(SD)) were 0.1 (±0.7) mm, 1.4 (±2.7) mm, and -0.4 (±1.9) mm 
in the left-right(L-R), anteroposterior (A-P), and superoinferior (S-I) 
directions, respectively. Average amount of deformation of the 
prostate surface (±1 SD) were 0.1 (±1.7)mm, 0.0 (±2.1) mm, and 0.5 
(±1.5) mm in the L-R, A-P, and S-I directions, respectively. The largest 
deformation of the prostate surface was 13.1 mm at the tip of the 
prostate in the A-P direction. According to Spearman rank correlation 
analysis, A-P shift of the CoG of the prostate had a highly significant 
relationship with deformation of the superior-posterior region (r 
=0.81, p < 0.001), middle-anteriorregion (r = 0.80, p < 0.001), and 
middle-posterior region (r = 0.81, p < 0.001) of the prostate surface. 
However, there was no significant correlation between shift of the 
CoG of the prostate and the SD of amount of deformation of the 
prostate surface in all directions. 
 
Conclusions: We found that A-P shift of the CoG of the prostate had a 
highly significant relationship with deformation of the superior-
posterior region, middle-anterior region and middle-posterior region 
of the prostate surface. The internal margin (IM) for IGRT of the 
prostate should be taken into account for the prostate deformation. 
For reducing the IMs and using adaptive radiationtherapy for prostate 
cancer, this analysis method might be useful. 
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Purpose/Objective: To evaluate the role of a specific dietary protocol 
combined with the use of Image Guided Radiation Therapy (IGRT) in 
managing late rectal adverse effects >G2 in prostate patients treated 
with a total dose of 76 Gy delivered with 3D-CRT. 
Materials and Methods: A commercial linear accelerator Elekta 
Synergy Beam Modulator integrated with a Cone Beam Computed 
Tomography (CBCT) for IGRT was used. 20 prostate patients were told 
to follow a dietary protocol. In order to verify the daily setup of the 
patients an XVI software which co-registrates images of CBCT scan and 
CT planning scan (pCT) was employed. An off line analysis allowed to 
obtain, from the shapes of the rectum,a mean dose volume histogram 
(<DVH>) averaging the DVHs of the rectums as they appeared in every 
verification CBCT. A geometrical model of a rectum was considered 
using the rectal contours delineated on the CBCT scans and was 
referred as 'Average Rectum' (AR); the corresponding DVH referred as 
DVH_AR. In addition, we evaluated the DVHs related to the first only 5 
CBCT scans ( and DVH_AR5). To compare the dose volume histograms, 
we used the Lyman-Kutcher-Burman (LKB) model with parameters n, 
m and TD50 established by QUANTEC (Quantitative Analysis of Normal 
Tissue Effects in the Clinic) named NTCPpCT, NTCP<DVH5>, NTCP<DVH> , 
NTCPAR5 and NTCPAR. The NTCP values have been also put in 
comparison to late rectal toxicity from follow-up data. Finally, using 
gamma distributions, we have analysed all the DVHs considering 
QUANTEC dose-volume constraints more restrictive from that used in 
our institution. 
Results: No patient developed late rectal toxicity after two years of 
follow up. The Pearson correlation test on NTCP values shows a strong 
correlation except for NTCPpCT. The Wilcoxon Rank Sum test display a 
statistically significant difference (p<0.01) between the NTCP values 
except for the couple NTCPAR5 and NTCPAR such as for the couple NTCP 
and NTCP. The DVH set which gives an NTCP closer to the clinical 
results is the one extracted from the AR. Finally, from the analysis of 
gamma distributions, we found that in most of patients, the DVH of 
pCT was not within the QUANTEC constraints while DVH of AR 
respected constraints except for 1 patient and 1 constraint. An 
example of gamma distributions plots for two patients and for the 
reference dose level of 65 Gy; the red line is the value that 
corresponds to the percentage of volume established by QUANTEC 
constraints (VQ65); the green line and the blue line are the value 
corresponding to the percentage of volume of AR and pCT 
respectively. The two plots correspond to two patients that both have 
(VpCT65) higher than(VQ65) but on the right VAR65 is higher than VQ65 , as 
well, while on the left it is less than VQ65 indicating an improvement of 
the DVH during the treatment.  
